Congratulations, Dr. Henry Miller!

September 19, 2022

 Good afternoon, everyone! Please join us and Dr. Alexander J.R. Bishop in congratulating Henry Miller on his passing his PhD Defense with honors! Way to go Henry!!!!! _________________________________________________________ Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, [...]

UT Health SA Newsroom: The University of Texas Health Science Center at San Antonio moves up in Forbes Best-In-State Employers list

August 31, 2022

 Posted on August 29, 2022 at 10:39 am. Shared by Steven Lee Now ranked 12th; fifth among health care/social employers. The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has jumped to 12th on Forbes magazine’s list of Best-In-State Employers 2022, from 34th last year. UT Health San Antonio made the ranking of [...]

Dr. Zhao Lai to Receive NCI R50 Funding

August 24, 2022

 The National Cancer Institute (NCI) has recently awarded an R50 Research Specialist Award to Dr. Zhao Lai, Associate Professor/Research, Director of the Next-Generation Sequencing Shared Resource (NGSSR) in the NCI-designated Mays Cancer Center (MCC). This award, over five years, supports the development of a stable research career for Dr. Lai, an exceptional scientist who will [...]

Business Wire: Lantern Pharma Reports Second Quarter 2022 Financial Results and Operational Highlights, Scientific Collaborations Updates (Houghton)

August 9, 2022

 During Childhood Cancer Awareness Month in September, Lantern will host a KOL webinar featuring Dr. Peter Houghton, Ph.D., a leading expert in childhood cancers at the Greehey Children's Cancer Institute at the University of Texas San Antonio Health Science Center. The webinar will focus on challenges in drug development for pediatric cancers and preliminary results from [...]

Dr. Raushan Kurmasheva Received the CURE Childhood Cancer Award

June 24, 2022

 Abstract Atypical teratoid/rhabdoid tumors (AT/RT) of the brain and malignant rhabdoid tumors of the kidney (RTK) compose a group of highly malignant pediatric cancers known as malignant rhabdoid tumors (MRT). Both subtypes are characterized by the biallelic loss of the SMARCB1 gene (member of the human SWI/SNF complex), which is thought to function as a [...]

Angelina Vaseva, PhD, to Receive Voelcker Fund Award to Research Type 2 RAF Inhibitors for the Treatment of NF1-Associated MPNST

June 15, 2022

 Angelina Vaseva, Ph.D. Greehey CCRI Principal Investigator Assistant Professor, Molecular Medicine "Angelina Vaseva, PhD, is an assistant professor in the Department of Molecular Medicine and the Greehey Children’s Cancer Research Institute. Dr. Vaseva is receiving $350,000 over three years for her award as she received $100,000 last year as a Voelcker Fund Pilot Research Award [...]

Happy Birthday, Bill Greehey!

June 9, 2022

  Happy Birthday, Mr. Greehey! On this special day, everyone here at the Greehey Children's Cancer Research Institute wishes you all the very best, all the joy you can ever have, and may you be blessed abundantly today, tomorrow, and in the days to come! May you have a fantastic birthday and many more to come.

Nicole Hensch (Ignatius Lab) Successfully Defends PhD Thesis!

May 17, 2022

 “SNAI2 protection of rhabdomyosarcoma against ionizing radiation can be targeted through MEK inhibition in RAS-mutant fusion-negative tumors”               Nicole Hensch Mentor: Myron Ignatius, PhD Program: PhD Integrated Biomedical Sciences Cell Biology Genetics, and Molecular Medicine Discipline

Successful PhD Thesis Defense: Santosh Timilsina (Rao Lab)

May 13, 2022

 “Targeting Forkhead Box M1 as a Novel Approach to Inhibit Breast Cancer Growth and Progression” Santosh Timilsina Mentor:  Manjeet Rao, PhD Program: PhD Integrated Biomedical Sciences Cell Biology – Cancer Biology Discipline